T cell response in hepatitis C virus infection

Journal of Clinical Virology

Volumn 32, Issue 2, 2005, Pages 75-85

  Neumann Haefelin, C ^a   Blum, H E ^a   Chisari, F V ^b   Thimme, R ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

antigen presenting cell; APC; CC (cysteine cysteine) chemokine receptor; CCR; CMV; CTL; cytomegalovirus; cytotoxic T lymphocyte; DC; dendritic cell; HCV; hepatitis C virus; HIV; human immunodeficiency virus; IFN; IL; interferon; interleukin; LCMV

Indexed keywords

ANTIGEN; GAMMA INTERFERON; RNA; VIRUS PROTEIN;

ANTIBODY PRODUCTION; CELL MATURATION; CELLULAR IMMUNITY; CORRELATION ANALYSIS; CYTOTOXICITY; DENDRITIC CELL; DOWN REGULATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGY; LIVER; LIVER BIOPSY; LYMPHOCYTE FUNCTION; MACROPHAGE; MEMORY CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS LOAD; VIRUS MUTATION; VIRUS RESISTANCE;

ANIMALS; HEPACIVIRUS; HEPATITIS C; HUMANS; MICE; T-LYMPHOCYTES;

EID: 11844260627     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.05.008     Document Type: Review

References (107)

1. Aandahl E.M., Michaelsson J., Moretto W.J., Hecht F.M., Nixon D.F. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78:2004;2454-2459
2. Accapezzato D., Francavilla V., Paroli M., Casciaro M., Chircu L.V., Cividini A., et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J. Clin. Invest. 113:2004a;963-972
3. Accapezzato D., Francavilla V., Rawson P., Cerino A., Cividini A., Mondelli M.U., et al. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: the role of the virus. Eur. J. Immunol. 34:2004;438-446
4. Anthony D.D., Yonkers N.L., Post A.B., Asaad R., Heinzel F.P., Lederman M.M., et al. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J. Immunol. 172:2004;4907-4916
5. Apolinario A., Majano P.L., Alvarez-Perez E., Saez A., Lozano C., Vargas J., et al. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am. J. Gastroenterol. 97:2002;2861-2870
6. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M., Papagno L., et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8:2002;379-385
7. Bain C., Fatmi A., Zoulim F., Zarski J.P., Trepo C., Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology. 120:2001;512-524
8. Barnes E., Harcourt G., Brown D., Lucas M., Phillips R., Dusheiko G., et al. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology. 36:2002;743-754
9. Bassett S.E., Guerra B., Brasky K., Miskovsky E., Houghton M., Klimpel G.R., et al. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology. 33:2001;1479-1487
10. Battegay M., Fikes J., Di Bisceglie A.M., Wentworth P.A., Sette A., Celis E., et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69:1995;2462-2470
11. Bertoletti A., D'Elios M.M., Boni C., De Carli M., Zignego A.L., Durazzo M., et al. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology. 112:1997;193-199
12. Bigger C.B., Brasky K.M., Lanford R.E. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J. Virol. 75:2001;7059-7066
13. Bukh J., Miller R.H., Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver. Dis. 15:1995;41-63
14. Cerny A., McHutchison J.G., Pasquinelli C., Brown M.E., Brothers M.A., Grabscheid B., et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95:1995;521-530
15. Champagne P., Ogg G.S., King A.S., Knabenhans C., Ellefsen K., Nobile M., et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 410:2001;106-111
16. Chang K.M., Rehermann B., McHutchison J.G., Pasquinelli C., Southwood S., Sette A., et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J. Clin. Invest. 100:1997;2376-2385
17. Chang K.M., Thimme R., Melpolder J.J., Oldach D., Pemberton J., Moorhead-Loudis J., et al. Differential CD4 and CD8 T-cell responsiveness in hepatitis C virus infection. Hepatology. 33:2001;267-276
18. Chen M., Sallberg M., Sonnerborg A., Weiland O., Mattsson L., Jin L., et al. Limited humoral immunity in hepatitis C virus infection. Gastroenterology. 116:1999;135-143
19. Cooper S., Erickson A.L., Adams E.J., Kansopon J., Weiner A.J., Chien D.Y., et al. Analysis of a successful immune response against hepatitis C virus. Immunity. 10:1999;439-449
20. Crotta S., Stilla A., Wack A., D'Andrea A., Nuti S., D'Oro U., et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195:2002;35-42
21. Diepolder H.M., Gerlach J.T., Zachoval R., Hoffmann R.M., Jung M.C., Wierenga E.A., et al. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J. Virol. 71:1997;6011-6019
22. Diepolder H.M., Zachoval R., Hoffmann R.M., Wierenga E.A., Santantonio T., Jung M.C., et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:1995;1006-1007
23. Erickson A.L., Kimura Y., Igarashi S., Eichelberger J., Houghton M., Sidney J., et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity. 15:2001;885-895
24. Farci P., Alter H.J., Govindarajan S., Wong D.C., Engle R., Lesniewski R.R., et al. Lack of protective immunity against reinfection with hepatitis C virus. Science. 258:1992a;135-140
25. Farci P., London W.T., Wong D.C., Dawson G.J., Vallari D.S., Engle R., et al. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia. J. Infect. Dis. 165:1992;1006-1011
26. Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J.C., et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 288:2000;339-344
27. Ferrari C., Valli A., Galati L., Penna A., Scaccaglia P., Giuberti T., et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology. 19:1994;286-295
28. Foy E., Li K., Wang C., Sumpter R. Jr., Ikeda M., Lemon S.M., et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science. 300:2003;1145-1148
29. Frasca L., Del Porto P., Tuosto L., Marinari B., Scotta C., Carbonari M., et al. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells. J. Immunol. 163:1999;650-658
30. Freeman A.J., Pan Y., Harvey C.E., Post J.J., Law M.G., White P.A., et al. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J. Hepatol. 38:2003;349-356
31. Frese M., Schwarzle V., Barth K., Krieger N., Lohmann V., Mihm S., et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology. 35:2002;694-703
32. Fukuda R., Ishimura N., Ishihara S., Tokuda A., Satoh S., Sakai S., et al. Expression of interferon-alpha receptor mRNA in the liver in chronic liver diseases associated with hepatitis C virus: relation to effectiveness of interferon therapy. J. Gastroenterol. 31:1996;806-811
33. Gale M. Jr., Blakely C.M., Kwieciszewski B., Tan S.L., Dossett M., Tang N.M., et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol. Cell. Biol. 18:1998a;5208-5218
34. Gale M.J. Jr., Korth M.J., Katze M.G. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance. Clin. Diagn. Virol. 10:1998;157-162
35. Gallimore A., Glithero A., Godkin A., Tissot A.C., Pluckthun A., Elliott T., et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1998;1383-1393
36. Gerlach J.T., Diepolder H.M., Jung M.C., Gruener N.H., Schraut W.W., Zachoval R., et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T- cell response in acute hepatitis C. Gastroenterology. 117:1999;933-941
37. Gerlach J.T., Diepolder H.M., Zachoval R., Gruener N.H., Jung M.C., Ulsenheimer A., et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology. 125:2003;80-88
38. Grabowska A.M., Lechner F., Klenerman P., Tighe P.J., Ryder S., Ball J.K., et al. Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur. J. Immunol. 31:2001;2388-2394
39. Grakoui A., Shoukry N.H., Woollard D.J., Han J.H., Hanson H.L., Ghrayeb J., et al. HCV persistence and immune evasion in the absence of memory T cell help. Science. 302:2003;659-662
40. Gruener N.H., Gerlach T.J., Jung M.C., Diepolder H.M., Schirren C.A., Schraut W.W., et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J. Infect. Dis. 181:2000;1528-1536
41. Gruener N.H., Lechner F., Jung M.C., Diepolder H., Gerlach T., Lauer G., et al. Sustained dysfunction of antiviral CD8(+) t lymphocytes after infection with hepatitis C virus. J. Virol. 75:2001;5550-5558
42. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:2001;65-91
43. Hahn Y.S. Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion? Curr. Opin. Immunol. 15:2003;443-449
44. Hahn C.S., Cho Y.G., Kang B.S., Lester I.M., Hahn Y.S. The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology. 276:2000;127-137
45. He X.S., Rehermann B., Lopez-Labrador F.X., Boisvert J., Cheung R., Mumm J., et al. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc. Natl. Acad. Sci. USA. 96:1999;5692-5697
46. Heim M.H., Moradpour D., Blum H.E. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J. Virol. 73:1999;8469-8475
47. Hoffmann R.M., Diepolder H.M., Zachoval R., Zwiebel F.M., Jung M.C., Scholz S., et al. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology. 21:1995;632-638
48. Kamal S.M., Fehr J., Roesler B., Peters T., Rasenack J.W. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology. 123:2002;1070-1083
49. Kaneko T., Moriyama T., Udaka K., Hiroishi K., Kita H., Okamoto H., et al. Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope. Eur. J. Immunol. 27:1997;1782-1787
50. Kao J.H., Chen P.J., Wang J.T., Yang P.M., Lai M.Y., Wang T.H., et al. Superinfection by homotypic virus in hepatitis C virus carriers: studies on patients with post-transfusion hepatitis. J. Med. Virol. 50:1996;303-308
51. Kittlesen D.J., Chianese-Bullock K.A., Yao Z.Q., Braciale T.J., Hahn Y.S. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106:2000;1239-1249
52. Klenerman P., Cerundolo V., Dunbar P.R. Tracking T cells with tetramers: new tales from new tools. Nat. Rev. Immunol. 2:2002;263-272
53. Klenerman P., Zinkernagel R.M. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature. 394:1998;482-485
54. Koziel M.J., Dudley D., Afdhal N., Choo Q.L., Houghton M., Ralston R., et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:1993;7522-7532
55. Koziel M.J., Dudley D., Afdhal N., Grakoui A., Rice C.M., Choo Q.L., et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J. Clin. Invest. 96:1995;2311-2321
56. Koziel M.J., Dudley D., Wong J.T., Dienstag J., Houghton M., Ralston R., et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:1992;3339-3344
57. Lai M.E., Mazzoleni A.P., Argiolu F., De Virgilis S., Balestrieri A., Purcell R.H., et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet. 343:1994;388-390
58. Lauer G.M., Ouchi K., Chung R.T., Nguyen T.N., Day C.L., Purkis D.R., et al. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J. Virol. 76:2002;6104-6113
59. Lechner F., Wong D.K., Dunbar P.R., Chapman R., Chung R.T., Dohrenwend P., et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191:2000;1499-1512
60. Lee C.H., Choi Y.H., Yang S.H., Lee C.W., Ha S.J., Sung Y.C. Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages. Virology. 279:2001;271-279
61. Leroy V., Vigan I., Mosnier J.F., Dufeu-Duchesne T., Pernollet M., Zarski J.P., et al. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology. 38:2003;829-841
62. Limmer A., Ohl J., Kurts C., Ljunggren H.G., Reiss Y., Groettrup M., et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat. Med. 6:2000;1348-1354
63. Liu C., Zhu H., Tu Z., Xu Y.L., Nelson D.R. CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity. Hepatology. 37:2003;1335-1342
64. Longman R.S., Talal A.H., Jacobson I.M., Albert M.L., Rice C.M. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood. 103:2004;1026-1029
65. Lucas M., Vargas-Cuero A.L., Lauer G.M., Barnes E., Willberg C.B., Semmo N., et al. Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells. J. Immunol. 172:2004;1744-1753
66. Major M.E., Mihalik K., Puig M., Rehermann B., Nascimbeni M., Rice C.M., et al. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J. Virol. 76:2002;6586-6595
67. Mathai J., Shimoda K., Banner B.F., Mori M., Bonkovsky H.L., Barnard G.F. IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy. J. Interferon Cytokine Res. 19:1999;1011-1018
68. Matsumoto M., Hsieh T.Y., Zhu N., VanArsdale T., Hwang S.B., Jeng K.S., et al. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J. Virol. 71:1997;1301-1309
69. Mehta S.H., Cox A., Hoover D.R., Wang X.H., Mao Q., Ray S., et al. Protection against persistence of hepatitis C. Lancet. 359:2002;1478-1483
70. Minutello M.A., Pileri P., Unutmaz D., Censini S., Kuo G., Houghton M., et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J. Exp. Med. 178:1993;17-25
71. Missale G., Bertoni R., Lamonaca V., Valli A., Massari M., Mori C., et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest. 98:1996;706-714
72. Moskophidis D., Lechner F., Pircher H., Zinkernagel R.M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature. 362:1993;758-761
73. Narumi S., Tominaga Y., Tamaru M., Shimai S., Okumura H., Nishioji K., et al. Expression of IFN-inducible protein-10 in chronic hepatitis. J. Immunol. 158:1997;5536-5544
74. Nelson D.R., Marousis C.G., Davis G.L., Rice C.M., Wong J., Houghton M., et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J. Immunol. 158:1997;1473-1481
75. Neumann A.U., Lam N.P., Dahari H., Gretch D.R., Wiley T.E., Layden T.J., et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science. 282:1998;103-107
76. Nuti S., Rosa D., Valiante N.M., Saletti G., Caratozzolo M., Dellabona P., et al. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis. Eur. J. Immunol. 28:1998;3448-3455
77. Orland J.R., Wright T.L., Cooper S. Acute hepatitis C. Hepatology. 33:2001;321-327
78. Ou R., Zhou S., Huang L., Moskophidis D. Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 75:2001;8407-8423
79. Parkin J., Cohen B. An overview of the immune system. Lancet. 357:2001;1777-1789
80. Penna A., Missale G., Lamonaca V., Pilli M., Mori C., Zanelli P., et al. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C. Hepatology. 35:2002;1225-1236
81. Prince A.M., Brotman B., Huima T., Pascual D., Jaffery M., Inchauspe G. Immunity in hepatitis C infection. J. Infect. Dis. 165:1992;438-443
82. Proust B., Dubois F., Bacq Y., Le Pogam S., Rogez S., Levillain R., et al. Two successive hepatitis C virus infections in an intravenous drug user. J. Clin. Microbiol. 38:2000;3125-3127
83. Rehermann B., Chang K.M., McHutchinson J., Kokka R., Houghton M., Rice C.M., et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J. Virol. 70:1996;7092-7102
84. Rollier C., Drexhage J.A., Verstrepen B.E., Verschoor E.J., Bontrop R.E., Koopman G., et al. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology. 38:2003;851-858
85. Sarobe P., Lasarte J.J., Casares N., Lopez-Diaz de Cerio A., Baixeras E., Labarga P., et al. Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J. Virol. 76:2002;5062-5070
86. Schirren C.A., Jung M.C., Gerlach J.T., Worzfeld T., Baretton G., Mamin M., et al. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology. 32:2000;597-603
87. Shoukry N.H., Grakoui A., Houghton M., Chien D.Y., Ghrayeb J., Reimann K.A., et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 197:2003;1645-1655
88. Su A.I., Pezacki J.P., Wodicka L., Brideau A.D., Supekova L., Thimme R., et al. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl. Acad. Sci. USA. 99:2002;15669-15674
89. Sugimoto K., Ikeda F., Stadanlick J., Nunes F.A., Alter H.J., Chang K.M. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology. 38:2003;1437-1448
90. Takaki A., Wiese M., Maertens G., Depla E., Seifert U., Liebetrau A., et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 6:2000;578-582
91. Tan S.L., Katze M.G. How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology. 284:2001;1-12
92. Taylor D.R., Shi S.T., Romano P.R., Barber G.N., Lai M.M. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science. 285:1999;107-110
93. Thimme R., Bukh J., Spangenberg H.C., Wieland S., Pemberton J., Steiger C., et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc. Natl. Acad. Sci. USA. 99:2002;15661-15668
94. Thimme R., Oldach D., Chang K.M., Steiger C., Ray S.C., Chisari F.V. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194:2001;1395-1406
95. Tsai S.L., Chen Y.M., Chen M.H., Huang C.Y., Sheen I.S., Yeh C.T., et al. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. Gastroenterology. 115:1998;954-965
96. Tseng C.T., Klimpel G.R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195:2002;43-50
97. Ulsenheimer A., Gerlach J.T., Gruener N.H., Jung M.C., Schirren C.A., Schraut W., et al. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology. 37:2003;1189-1198
98. Urbani S., Boni C., Missale G., Elia G., Cavallo C., Massari M., et al. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J. Virol. 76:2002;12423-12434
99. Wedemeyer H., He X.S., Nascimbeni M., Davis A.R., Greenberg H.B., Hoofnagle J.H., et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 169:2002;3447-3458
100. Weiner A., Erickson A.L., Kansopon J., Crawford K., Muchmore E., Hughes A.L., et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA. 92:1995;2755-2759
101. Weiner A.J., Paliard X., Selby M.J., Medina-Selby A., Coit D., Nguyen S., et al. Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity. J. Virol. 75:2001;7142-7148
102. Willberg C., Barnes E., Klenerman P. HCV immunology - death and the maiden T cell. Cell Death Differ. 10:2003;S39-S47
103. Wong D.K., Dudley D.D., Afdhal N.H., Dienstag J., Rice C.M., Wang L., et al. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J. Immunol. 160:1998;1479-1488
104. Wong D.K., Dudley D.D., Dohrenwend P.B., Lauer G.M., Chung R.T., Thomas D.L., et al. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. J. Virol. 75:2001;1229-1235
105. Yao Z.Q., Nguyen D.T., Hiotellis A.I., Hahn Y.S. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J. Immunol. 167:2001;5264-5272
106. Zajac A.J., Blattman J.N., Murali-Krishna K., Sourdive D.J., Suresh M., Altman J.D., et al. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:1998;2205-2213
107. Zhu N., Ware C.F., Lai M.M. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. Virology. 283:2001;178-187